Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 14, 2020

SELL
$16.28 - $25.63 $718,436 - $1.13 Million
-44,130 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$18.01 - $20.11 $88,789 - $99,142
4,930 Added 12.58%
44,130 $0
Q2 2018

Aug 15, 2018

SELL
$20.16 - $24.68 $403,200 - $493,600
-20,000 Reduced 33.78%
39,200 $0
Q3 2017

Nov 14, 2017

BUY
$20.07 - $21.89 $1.19 Million - $1.3 Million
59,200
59,200 $0

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.57B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Paradigm Asset Management CO LLC Portfolio

Follow Paradigm Asset Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Asset Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Asset Management CO LLC with notifications on news.